No abstract

Trial registration number: Clinicaltrials.gov NCT04896879, https://clinicaltrials.gov/ct2/show/NCT04896879. †The members of the Belgian LARS collaborative group can be found in the acknowledgements.

Standardization of the OPAT program aims at improving quality and safety of intravenous antimicrobial therapy in the home setting.

No abstract

Background: Chemotherapy-induced peripheral neuropathy (CIPN), characterised by subjective sensory and motor symptoms felt on hands and feet, is one of the less known side-effects of chemotherapy. For many patients, their awareness of CIPN begins with information provided by clinicians during pre-chemotherapy consultations. However, there is limited understanding of how patients develop their understanding and perception of CIPN or of the experiences of clinicians providing CIPN information. This study explored patient's and clinician's experience of care provision, information and support for CIPN.Methods: Data collection was conducted between July-November 2019 in a London hospital using multiple qualitative methods. Non-participant observations of prechemotherapy consultations between clinicians and people with breast or colorectal cancer (n¼ 9) were conducted. We also undertook semi-structured interviews with people who had breast or colorectal cancer (n¼11) and clinicians (n¼9). Data were analysed using inductive reflexive thematic analysis.